Cargando…

Targeted Therapy in Biliary Tract Cancers

A paradigm shift towards molecular-based, personalized cancer therapeutics has occurred in recent years and a number of targeted drugs have emerged. Various targeted therapies like erlotinib, trastuzumab, and cetuximab have been approved in lung, breast, and colon cancers, respectively. Numerous cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Merla, Amartej, Liu, Kenneth G., Rajdev, Lakshmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534500/
https://www.ncbi.nlm.nih.gov/pubmed/26266637
http://dx.doi.org/10.1007/s11864-015-0366-0

Ejemplares similares